Pharmacology

Top Story

Novel oxycodone abuse-deterrent formula effective for chronic pain

September 22, 2017

Oxycodone DETERx ER, an extended-release, abuse-deterrent drug, safely and effectively managed chronic pain in patients with poorly managed pain previously treated with immediate-release oxycodone, according to data presented at PAINWeek.

“Converting patients previously taking immediate-release [IR] opioid medications to extended-release [ER] products is common clinical practice; however, there is little to no scientific literature available that specifically examines it,” Diana Meske, study researcher with Collegium Pharmaceutical, told Healio Internal Medicine. “Collegium believes that it is important to provide clinicians with as much relevant data when considering treatment options, or changes to treatment, for their patients and thus sought to complete a post-hoc analysis of the results from our phase 3 efficacy and safety study used to support approval of [oxycodone DETERx ER (Xtampza ER)].”

FDA News

FDA: Patients receiving incorrect Ocaliva dosage, reports of liver injury

September 21, 2017
The FDA released a report today that Ocaliva has been incorrectly prescribed to some patients with moderate to severe liver impairment and may be tied to cases of liver…
FDA News

FDA advises on medication-assisted treatment for individuals taking depressants

September 20, 2017
The FDA today issued a Drug Safety Communication advising that buprenorphine and methadone should not be withheld from individuals receiving benzodiazepines or other…
In the Journals

Opioid use in breast cancer patients linked to treatment nonadherence

September 20, 2017
Breast cancer patients who use opioids to manage their pain are significantly less likely to adhere to vital adjuvant endocrine therapies and are at a significantly…
More Headlines »
CME Video

Navigating a New Era of Personalized Type 2 Diabetes Care: Taking the Road Less Traveled

This activity is supported by an independent educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

In the United States, over 29 million people have diabetes, of which approximately 95% of cases are type 2 diabetes…
More »
GI Bookshelf

Question 37: Which Asymptomatic Patients With Cirrhosis Should Undergo An Upper Endoscopy To Determine Whether They Have Esophageal Varices?

From Curbside Consultation of the Liver: 49 Clinical Questions
More »
Resource Centers
American Association of Nurse Practitioners National Conference

American Association of Nurse Practitioners National Conference

Video
Meeting News Coverage

VIDEO: Improving treatment options yielding better results for comorbidities in patients with diabetes

May 7, 2016
More »
Advertisement
Advertisement